Looking forward to when #retatrutide's Phase 3 trial results will become available
Dead volume in syringes, residual material left in vials, and small measurement errors typically result in 3-8% product waste
In recent years, some people have not been able to get access to their GLP-1 RA medication because of shortages
Maintenance and Long-Term Success Continued support to keep weight off, incorporating lifestyle adjustments for patients facing Austins unique wellness barriers
CVS Caremark's decision is not in the best interest of patients, and heres why: Zepbound Demonstrates Superior Efficacy : Clinical evidence, most notably the head-to-head SURMOUNT-5 trial, showed that patients on Zepbound achieved significantly greater average weight loss (20.2%) compared to those on Wegovy (13.7%) over 72 weeks
It is a two-part trial where 1,197 participants were randomized 2:1 to receive semaglutide 2.4 mg or placebo, on top of standard of care for 240 weeks